Document is current
Any future updates will be listed below
-
Authors
Feinkohl, Insa https://orcid.org/0000-0002-0307-1862
Janke, Jürgen
Hadzidiakos, Daniel
Slooter, Arjen
Winterer, Georg
Spies, Claudia
Pischon, Tobias
-
Funding
Funding for this research was provided by:
FP7 Health (HEALTH‐F2‐2014‐602461)
- License Information
-
More Information
Article History
Received: 7 September 2018
Accepted: 18 February 2019
First Online: 7 March 2019
Ethics approval and consent to participate
: The study was conducted in compliance with the Declaration of Helsinki. All participants gave written informed consent. The study protocol was approved by the institutional ethics review boards (Ethikkommission, Ethikausschuss 2 am Campus Virchow-Klinikum, Charité Universitatsmedizin Berlin, Reference EA2/092/14; Medisch Ethische Toetsingscommissie, UMC Utrecht, Reference 14/469).
: Not applicable.
: GW is coordinator of the BioCog consortium and is chief executive of the company Pharmaimage Biomarker Solutions GmbH (). Among other academic and private partners, the company is a partner of the BioCog study. CS and TP are project leaders in BioCog. CS, TP, AS, JJ, DH and IF declare that they have no conflicts of interest related to this article.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
